The 2027 sponsor and exhibitor list is not published yet (the organizer’s page still shows last year’s). We’ll add the exhibitors and their booths when it is, along with new sessions as the agenda fills in.

Astellas Gene Therapies at BPI West 2027

Mar 16–18, 2027 San Diego, CA ~800 attendees Website

Astellas Gene Therapies takes part in 2 sessions at BPI West 2027 in San Diego. Its sessions centre on speeding up AAV process development. They cover SEC-MALS analysis and automated, high-throughput chromatography screening to move AAV downstream development along faster.

OrganizationBPI West 2027 Attendance
Large pharma
Gene therapy unit of Astellas Pharma, developing and manufacturing AAV-based gene therapies for rare genetic diseases.
Talk
Wed Mar 17
11:45am–12:15pm
Accelerating AAV Process Development Through SEC-MALS
Next-Gen Modality, Cell Therapy, and Gene Therapy Development & Production
Talk
Wed Mar 17
2:30pm–3:00pm
Accelerating AAV Downstream Process Development Through Automated, High-Throughput Chromatography Screening
Next-Gen Modality, Cell Therapy, and Gene Therapy Development & Production

Explore the full BPI West 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full BPI West 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Astellas Gene Therapies

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by BioProcess International or its organizers. Submit a correction